Vascular dementia

Seminars in Clinical Neuropsychiatry

Volumn 8, Issue 1, 2003, Pages 37-45

  Erkinjuntti, Timo ^a   Rockwood, Kenneth ^b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b DALHOUSIE UNIVERSITY   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; DEGENERATIVE DISEASE; DISEASE CLASSIFICATION; FUNCTIONAL DISEASE; HUMAN; MULTIINFARCT DEMENTIA; RISK FACTOR; WHITE MATTER; AGED; ALZHEIMER DISEASE; BRAIN; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PROGNOSIS; PSYCHOLOGICAL ASPECT; REVIEW;

AGED; ALZHEIMER DISEASE; BRAIN; DEMENTIA, MULTI-INFARCT; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS;

EID: 0037261315     PISSN: 10843612     EISSN: None     Source Type: Journal    
DOI: 10.1053/scnp.2003.50004     Document Type: Conference Paper

References (75)

1. Torak RM (ed): The Pathologic Physiology of Dementia. With Indications for Diagnosis and Treatment. Berlin, Germany, Springer-Verlag, 1978
2. Hackinski VC, Lassen NA, Marshall J: Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 2:207-210, 1974
3. Tatemichi TK: How acute brain failure becomes chronic. A view of the echanisms and syndromes of dementia related to stroke. Neurology 40:1652-1659, 1990
4. Erkinjuntti T, Hachinski VC: Rethinking vascular dementia. Cerebrovasc Dis 3:3-23, 1993
5. Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250-260, 1993
6. Chui HC, Victoroff JI, Margolin D, et al: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's disease Diagnostic and Treatment Centers. Neurology 42:473-480, 1992
7. Hachinski VC, Lliff LD, Zilhka E, et al: Cerebral blood flow in dementia. Arch Neurol 32:632-637, 1975
8. Wetterling T, Kanitz RD, Borgis KJ: Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 27:30-36, 1996
9. Erkinjuntti T, Ostbye T, Steenhuis R, et al: The effect of different diagnostic criteria on the prevalence of dementia. New Engl J Med 337:1667-1674, 1997
10. Skoog I, Nilsson L, Palmertz B, et al: A population-based study of dementia in 85-year-olds. New Engl J Med 328:153-158, 1993
11. Pohjasvaara T, Erkinjuntti T, Vataja R, et al: Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 28: 785-792, 1997
12. Erkinjuntti T, Bowler JV, DeCarli C, et al: Imaging of static brain lesions in vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord 13:S81-S90, 1999 (suppl)
13. Verhey FR, Lodder J, Rozendaal N, et al: Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 15:166-172, 1996
14. Gold G, Giannakopoulos P, Montes-Paixao JC, et al: Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 49: 690-694, 1997
15. Lopez OL, Larumbe MR, Becker JT, et al: Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 44:1240-1245, 1994
16. Chui HC, Mack W, Jackson E, et al: Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and inter-rater reliability. Arch Neurol 57:191-196, 2000
17. Rocca WA, Hofman A, Brayne C, et al: The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group. Ann Neurol 30:817-824, 1991
18. Lobo A, Launer LJ, Fratiglioni L, et al: Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology 54: S4-S9, 2000 (suppl)
19. Rockwood K: Lessons from mixed dementia. Int Psychogeritr 9:245-249, 1997
20. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS): Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 359:624-625, 2000
21. Rockwood K, Wenzel C, Hachinski V, et al: Prevalence and outcomes of vascular cognitive impairment. Neurology 54:447-451, 2000
22. Wentzel C, Rockwood K, MacKnight C, et al: Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 57:714-716, 2001
23. Ingles JL, Wentzel C, Fisk JD, et al: Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment without dementia. Stroke 33:1999-2002, 2002
24. Rockwood K, Brown M, Merry H, et al: Societal costs of vascular cognitive impairment in older adults. Stroke 33:1605-1609, 2002
25. Hebert R, Brayne C: Epidemiology of vascular dementia. Neuroepidemiology 14:240-257, 1995
26. Fratiglioni L, Launer LJ, Andersen K, et al: Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology 54: S10-S15 2000 (suppl)
27. Hébert R, Lindsay J, Verreault René, et al: Vascular dementia. Incidence and risk factors in the Canadian Study of Health and Aging. Stroke 31:1487-1493, 2000
28. Chui HC: Dementia: a review emphasizing clinicopathologic correlation and brain-behavior relationships. Arch Neurol 46:806-814, 1989
29. Desmond DW: Vascular dementia: a construct in evolution. Cerebrovascular Brain Metabolism Rev 8:296-325, 1996
30. Wolfson C, Wolfson D, Asgharian M, et al: A re-evaluation of the duration of survival from the onset of dementia. New Engl J Med 344:1111-1116, 2001
31. Kittner B, De Deyn PP, Erkinjuntti T: Investigating the natural course and treatment of vascular dementia and Alzheimer's disease. Parallel study populations in two randomized, placebo-controlled trials. Ann N Y Acad Sci 903:535-541, 2000
32. Winblad B, Poritis N: Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 14:135-146, 1999
33. Erkinjuntti T, Kurz A, Gauthier S, et al: Galantamine is efficacious in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease. Lancet (in press)
34. Rockwood K: Prognosis of vascular cognitive impairment and its subtypes. Old Age Psychiatry (in press)
35. Royall D, Roman G: Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord 13:S69-S80, 1999 (suppl)
36. Scheltens PH: Structural neuroimaging of Alzheimer's disease and other dementias. Aging 13:203-209, 2001
37. Bowler JV, Steenhuis R, Hachinski V: Conceptual background of vascular cognitive impairment. Alzheimer Dis Assoc Disord 13:S30-S37, 1999 (suppl)
38. Erkinjuntti T, Rockwood K: Vascular cognitive impairment. Psychogeriatrics 1:27-38, 2001
39. Pasquier F, Leys D: Why are stroke patients prone to develop dementia? J Neurology 244:135-142, 1997
40. Skoog I: Status of risk factors for vascular dementia. Neuroepidemiology 17:2-9, 1998
41. Brun A: Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 5:145-147, 1994
42. Amar K, Wilcock G: Vascular dementia. Br Med J 312: 227-231, 1996
43. Pantoni L, Garcia JH: The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 26:1293-1301, 1995
44. Erkinjuntti T, Haltia M, Palo J, et al: Accuracy of the clinical diagnosis of vascular dementia: a rospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 51:1037-1044, 1988
45. Breteler MM: Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 21:153-160, 2000
46. Rockwood K: Vascular risk factors in dementia. J Geriatric Care 1:141-146, 2002
47. Rockwood K, Howard K, MacKnight C, et al: Spectrum of disease in vascular cognitive impairment. Neuroepidemiology 18:248-254, 1999
48. Mielke R, Herholz K, Grond M, et al: Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 49:909-913, 1992
49. Tatemichi TK, Paik M, Bagiella E, et al: Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44:1885-1891, 1994
50. Snowdon DA, Greiner LH, Mortimer JA, et al: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277:813-817, 1997
51. Vinters HV, Ellis WG, Zarow C, et al: Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59:931-945, 2000
52. Pohjasvaara T, Mantyla R, Salonen O, et al: MRI correlates of dementia after first clinical ischemic stroke. J Neurol Sci 181:111-117, 2000
53. Roessmann U, Friede RL: Changes in butyryl cholines terase activity in reactive glia. Neurology 16:123-129, 1966
54. Zhou J, Zhang HY, Tang XC: Huperzine A attenuates cognitive deficits and hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett 313:137-140, 2001
55. Block F: Global ischemia and behavioural deficits. Prog Neurobiol 58:279-295, 1999
56. Hachinski V: Preventable senility: a call for action against the vascular dementias. J Am Ger Soc 340: 645-648, 1992
57. Petersen RC, Doody R, Kurz A, et al: Current concepts in mild cognitice impairment. Arch Neurol 58:1985-1992, 2002
58. DiCarlo A, Baldereschi M, Amaducci L, et al: Cognitive impairment without dementia in older people: Prevalence, vascular risk factors, impact on disability, The Italian Longitudinal Study on Aging, J Am Geriatric Soc 48:774-782, 2000
59. Ballard C, McKeith I, O'Brien J, et al: Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes, Dementia Geriatr Cogn Disord 11:59-65, 2000
60. Rockwood K, MacKnight C, Wentzel C, et al: The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC). Ann NY Acad Sci 903:522-528, 2000
61. Erkinjuntti T: Cerebrovascular dementia. Pathophysiology, diagnosis and treatment. CNS Drugs 12:35-48, 1999
62. Doody RS, Stevens JC, Beck C, et al: Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:1154-1166, 2001
63. Forette F, Seux ML, Staessen JA, et al: The prevention of dementia with antihypertensive treatment: New evidence from the systolic hypertension in Europe (SystEur) study. Arch Intern Med 162:2046-2052, 2002
64. Progress Investigators: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack, Lancet 358:1033-1041, 2001
65. Konno S, Meyer JS, Terayama Y, et al: Classification, diagnosis and treatment of vascular dementia, Drugs & Aging 11:361-373, 1997
66. Erkinjuntti T: Vascular dementia: challenge of clinical diagnosis, Int Psychogeriatr 9:51-58, 1997 (suppl 1)
67. Knezevic S, Labs KH, Kittner B, et al: The treatment of vascular dementia: problems and prospects, in Prohovnik L, Wade J, Knesevich J, et al (eds): Vascular Dementia. Current concepts. Chister, John Wiley & Sons, 1996, pp 301-312
68. Pantoni L, Carosi M, Amigoni S, et al: A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis. Clinical Neuropharmacol 19:497-506, 1996
69. Pischel T: Long-term efficacy and safety of propentofylline in patients with vascular dementia. Results of a 12 month placebo-controlled trial, Neurobiol Aging 19: S182, 1998 (suppl)
70. Winblad B, Poritis N: Memantine in severe dementia. Results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 14:135-146, 1999
71. Orgogozo J-M, Rigaud A-S, Stöffler A, et al: Efficacy and safety of memantine in patients with mild to moderate vascular dementia, Stroke 33:1843-1839, 2002
72. Erkinjuntti T, Kurz A, Gauthier S, et al: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Lancet 359:1283-1290, 2002
73. Pratt RD, Perdomo CA, and The Donepezil 308 VaD Study Group: Cognitive and Global Benefits of donepezil in vascular dementia: Results from study 308, a 24-week, randomized, double-blind, placebo-controlled trial and The Donepezil 308 VaD Study Group. Abstract presented at the 2nd International Congress on Vascular Dementia, Salzburg, Austria, January 25-27, 2002
74. th International Conference on Alzheimer's disease and Related Disorders, Stockholm, Sweden, July 20-25, 2002
75. Rockwood K: Vascular cognitive impairment and vascular dementia, J Neurol Sci 203-204(c):24-27.